The stock has had a terrific year, but RBC analyst Paul Treiber thinks there is still money to be made on Celestica (Celestica Stock Quote, Chart, News, Analysts, Financials NYSE:CLS).
In a research update to clients July 25, Treiber maintained his “Buy” rating and price target of $65.00 on CLS.
On July 24, CLS reported its Q2, 2024 results. The company posted EPS of $0.83 on revenue of $2.39-billion, a topline that was up 23% year-over-year.
“We are pleased to deliver another quarter of very strong performance in Q2 2024, with revenue up 23% year-to-year and non-IFRS adjusted EPS* up 65% year-to-year”. CEO Rob Mionis said. “With our strong performance in the first half of the year and favorable demand dynamics continuing, we are pleased to raise our full year 2024 outlook. We anticipate achieving revenue of $9.45 billion and non-IFRS adjusted EPS* of $3.62 in 2024, which, if achieved, would represent 19% and 49% growth, respectively, compared to 2023. We continue to stay focused on solid execution for our customers, and delivering on our strategic priorities and financial targets.”
Following in-person meetings with management, ATB Capital analyst Martin Toner likes what he sees from Thinkific Labs (Thinkific Labs Stock… [Read More]
Following the company's second quarter results, National Bank Financial analyst John Shao has raised his price target on D2L (D2L… [Read More]
"A misunderstood innovator". That's what Ventum Capital Markets analyst Amr Ezzat thinks about Blackline Safety (Blackline Safety Stock Quote, Chart,… [Read More]
With sales soaring, Haywood analyst Gianluca Tucci has raised his price target on Kits Eyecare (Kits Eyecare Stock Quote, Chart,… [Read More]
Potential retaliation and higher prices. Those are some of the things Canada may be setting up for with its decision… [Read More]
Following a major development, Roth MKM analyst Leo Marinari has maintained his "Buy" rating on LanzaTech Global (Lanzatech Global Stock… [Read More]